InterSystems IRIS for Health Selected by Konica Minolta Japan for HL7® Rapid FHIR-Based Data Integration for Imaging Devices

InterSystems IRIS for Health is the world’s first and only data platform developed specifically for extracting value from medical data.

InterSystems IRIS for Health was selected by Konica Minolta Japan as the underlying technology for its new software systems that enable the Japanese tech giant’s devices to rapidly integrate patient data with other hospital systems.

Utilizing the HL7® FHIR® standard, the software supports the automated connection, visualization and use of medical data between Konica Minolta Japan’s devices and other hospital systems such as the electronic medical record (EMR).

InterSystems IRIS for Health is the world’s first and only data platform specifically engineered to extract value from healthcare data. On this platform, developers can create and scale healthcare applications with tools that are uniquely designed to meet the current and future needs of modern healthcare.

View video here.

Konica Minolta Japan is a mission-driven digital company offering a wide range of solutions spanning different markets. Within healthcare, the company provides diagnostic imaging and ultrasound systems, as well as solutions for centralized management and utilization of medical records for medical facilities, including filing, and document systems.

Under this agreement, InterSystems will provide IRIS for Health to Konica Minolta Japan to help their new system development that supports the automated connection, visualization and use of all medical data typically found scattered across various systems including electronic health records, diagnostic imaging, laboratory, document systems and more. Through this partnership, InterSystems supports Konica Minolta Japan’s aims to contribute to improved patient care quality and safety, in addition to efficiency gains.

“We are very pleased that InterSystems IRIS for Health’s HL7®FHIR® capability, the new standard for medical information exchange, and its ability to process medical data at high speed, have been highly regarded by Konica Minolta Japan and they’ve chosen InterSystems IRIS for Health as the core technology of their healthcare system development,” said Masane Hayashi, country manager for InterSystems in Japan.

Hayashi concluded, “Through the interoperability of FHIR and our support for the development of new systems that process and analyze vast amounts of medical information at high speed, we are pleased to help that the necessary information be delivered to the healthcare professionals who need it and to contribute in reducing alert fatigue among healthcare professionals, which is becoming an increasing social problem.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”